The store will not work correctly when cookies are disabled.
N-[4-[Ethyl(isopropyl)amino]phenyl]isothiazole-4-carboxamide
ID: ALA4573705
PubChem CID: 155563237
Max Phase: Preclinical
Molecular Formula: C15H19N3OS
Molecular Weight: 289.40
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCN(c1ccc(NC(=O)c2cnsc2)cc1)C(C)C
Standard InChI: InChI=1S/C15H19N3OS/c1-4-18(11(2)3)14-7-5-13(6-8-14)17-15(19)12-9-16-20-10-12/h5-11H,4H2,1-3H3,(H,17,19)
Standard InChI Key: ZAJXIXCPAWYANV-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 21 0 0 0 0 0 0 0 0999 V2000
16.5792 -27.6178 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.5730 -28.4391 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
17.3519 -28.6993 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8431 -28.0400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3618 -27.3735 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6603 -28.0461 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0742 -27.3414 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.0636 -28.7568 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.8808 -28.7629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2822 -29.4757 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0986 -29.4821 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5133 -28.7769 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1056 -28.0638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2905 -28.0609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3305 -28.7819 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.7347 -29.4921 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7434 -28.0767 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5519 -29.4971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5605 -28.0817 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3391 -27.3665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 1 2 0
4 6 1 0
6 7 2 0
6 8 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
12 15 1 0
15 16 1 0
15 17 1 0
16 18 1 0
17 19 1 0
17 20 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 289.40 | Molecular Weight (Monoisotopic): 289.1249 | AlogP: 3.63 | #Rotatable Bonds: 5 |
Polar Surface Area: 45.23 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 5.42 | CX LogP: 3.27 | CX LogD: 3.27 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.91 | Np Likeness Score: -1.80 |
References
1. Jumppanen M, Kinnunen SM, Välimäki MJ, Talman V, Auno S, Bruun T, Boije Af Gennäs G, Xhaard H, Aumüller IB, Ruskoaho H, Yli-Kauhaluoma J.. (2019) Synthesis, Identification, and Structure-Activity Relationship Analysis of GATA4 and NKX2-5 Protein-Protein Interaction Modulators., 62 (17): [PMID:31431011] [10.1021/acs.jmedchem.9b01086] |